Brinda Balasubramanian

Bangkok, 10400, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Transcriptomic Correlation Identifies Cell Model Representatives for MYCN-Amplified Pediatric Neuroblastoma, Downstream Impact of Model Choice on Functional Interpretation, and Potential Drug Repositioning Candidates.

Transcriptomic Correlation Identifies Cell Model Representatives for MYCN-Amplified Pediatric Neuroblastoma, Downstream Impact of Model Choice on Functional Interpretation, and Potential Drug Repositioning Candidates.

Journal: Omics : a journal of integrative biology

Published: February 05, 2026

Co-Assembling 3D In Vitro Model to Recreate the Colorectal Tumor Microenvironment.

Co-Assembling 3D In Vitro Model to Recreate the Colorectal Tumor Microenvironment.

Journal: Advanced healthcare materials

Published: December 14, 2025

In0testinal stem and progenitor cells exhibit distinct adaptive responses to inflammatory stress in IBD.

In0testinal stem and progenitor cells exhibit distinct adaptive responses to inflammatory stress in IBD.

Journal: Stem cell research & therapy

Published: July 18, 2025

Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma.

Journal: Cancers

Published: October 09, 2024

Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells.

Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells.

Journal: Scientific reports

Published: September 17, 2024

Bioinformatic and experimental data pertaining to the role of the NLRP3 inflammasome in ovarian cancer.

Bioinformatic and experimental data pertaining to the role of the NLRP3 inflammasome in ovarian cancer.

Journal: Journal of cancer research and clinical oncology

Published: August 17, 2024

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 08, 2024

Targeting MYC at the intersection between cancer metabolism and oncoimmunology.

Targeting MYC at the intersection between cancer metabolism and oncoimmunology.

Journal: Frontiers in immunology

Published: October 18, 2023

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.

Journal: Frontiers in oncology

Published: March 12, 2023

Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.

Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.

Journal: Scientific reports

Published: February 20, 2023

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

Journal: Cancers

Published: February 16, 2023

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.

Journal: Molecules (Basel, Switzerland)

Published: June 30, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026